SEELAS Life Sciences (SLS) - 2024 Q4 - Annual Results

Exhibit 99.1 SELLAS Life Sciences Reports Full Year 2024 Financial Results and Provides Corporate Update NEW YORK, NY March 20, 2025 -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ("SELLAS'' or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today reported financial results for the full year ended December 31, 2024, and provided a corporate update. "We are pleased with the progress of our pipeline as we ...